GSK expects its sales and profit to grow in the new year after cancer treatments lifted sales and profit ahead of analysts' expectations in the fourth quarter despite lower vaccines sales on weak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback